| scholarly article | Q13442814 |
| P2093 | author name string | Pierre P Massion | |
| John F R Robertson | |||
| Herb F Sewell | |||
| Laura J Peek | |||
| Andrea Murray | |||
| Graham F Healey | |||
| Lynn Fredericks | |||
| P2860 | cites work | Reduced lung-cancer mortality with low-dose computed tomographic screening | Q28241954 |
| Projected cancer risks from computed tomographic scans performed in the United States in 2007 | Q28267626 | ||
| Probability of cancer in pulmonary nodules detected on first screening CT. | Q30573941 | ||
| Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules | Q33900761 | ||
| Technical validation of an autoantibody test for lung cancer | Q34024944 | ||
| A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules | Q34433475 | ||
| Clinical validation of an autoantibody test for lung cancer | Q34537374 | ||
| Limitations of screening for lung cancer with low-dose spiral computed tomography | Q36184968 | ||
| EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays | Q36285345 | ||
| Recent Trends in the Identification of Incidental Pulmonary Nodules | Q40692443 | ||
| Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice | Q43436848 | ||
| Early Lung Cancer Action Project: overall design and findings from baseline screening. | Q50649665 | ||
| Lung cancer screening with CT: Mayo Clinic experience. | Q50714825 | ||
| The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. | Q50958688 | ||
| EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer | Q56994727 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | computed tomography | Q32566 |
| autoantibody | Q785022 | ||
| P304 | page(s) | 578-584 | |
| P577 | publication date | 2016-09-08 | |
| P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
| P1476 | title | Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer | |
| P478 | volume | 12 |
| Q38689104 | AJRCCM: 100-Year Anniversary. The Shifting Landscape for Lung Cancer: Past, Present, and Future |
| Q62492568 | Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges |
| Q62490647 | Lung Cancer Screening, Towards a Multidimensional Approach: Why and How? |
| Q97539178 | Noninvasive biomarkers for lung cancer diagnosis, where do we stand? |
| Q46035215 | Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. |
| Q39438407 | Secreted tumor antigens - immune biomarkers for diagnosis and therapy. |
| Q41294153 | Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. |
Search more.